Form 8-K - Current report:
SEC Accession No. 0001493152-24-036161
Filing Date
2024-09-13
Accepted
2024-09-13 14:12:23
Documents
15
Period of Report
2024-09-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38432
2 ex10-1.htm EX-10.1 201709
3 ex10-2.htm EX-10.2 171682
  Complete submission text file 0001493152-24-036161.txt   665358

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE rgbp-20240904.xsd EX-101.SCH 3042
5 XBRL LABEL FILE rgbp-20240904_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE rgbp-20240904_pre.xml EX-101.PRE 24183
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3458
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-722-5505
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 333-191725 | Film No.: 241297315
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)